{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:44:30Z","timestamp":1782971070485,"version":"3.54.5"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/cnq.0b013e3182a10cbd","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T22:38:15Z","timestamp":1381531095000},"page":"335-344","source":"Crossref","is-referenced-by-count":4,"title":["Toxicologic Emergencies in the Intensive Care Unit"],"prefix":"10.1097","volume":"36","author":[{"given":"Sruti R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210126","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650.2012.746424","article-title":"2011 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 29th Annual Report.","volume":"50","author":"Bronstein","year":"2012","journal-title":"Clin Toxicol"},{"key":"R2-3-20210126","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2215\/CJN.03220807","article-title":"Toxic alcohol ingestions: clinical features, diagnosis, and management.","volume":"3","author":"Kraut","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-3-20210126","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM200102083440605","article-title":"Fomepizole for the treatment of methanol poisoning.","volume":"344","author":"Brent","year":"2001","journal-title":"N Engl J Med"},{"key":"R4-3-20210126","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199903183401102","article-title":"Fomepizole for the treatment of ethylene glycol poisoning.","volume":"340","author":"Brent","year":"1999","journal-title":"N Engl J Med"},{"key":"R5-3-20210126","first-page":"199","article-title":"Fomepizole in the treatment of ethylene glycol poisoning.","volume":"4","author":"Hall","year":"2002","journal-title":"CEJM"},{"key":"R6-3-20210126","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/15563650.2011.556642","article-title":"Outcomes of visual disturbances after methanol poisoning.","volume":"49","author":"Sanaei-Zadeh","year":"2011","journal-title":"Clin Toxicol"},{"key":"R7-3-20210126","first-page":"507","article-title":"4-Methyl-pyrazine (fomepizole) therapy of methanol poisoning: preliminary results of the META trial.","volume":"35","author":"Brent","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"R8-3-20210126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJM198807143190206","article-title":"Treatment of ethylene glycol poisoning with intravenous 4-methyl-pyrazole.","volume":"319","author":"Baud","year":"1988","journal-title":"N Engl J Med"},{"key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(99)80015-4","article-title":"Fomepizole in the treatment of uncomplicated ethylene glycol poisoning.","volume":"354","author":"Borron","year":"1999","journal-title":"Lancet"},{"key":"R11-3-20210126","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1081\/CLT-120006745","article-title":"American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning.","volume":"40","author":"Barceloux","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"R12-3-20210126","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1081\/CLT-100102445","article-title":"American Academy of Clinical Toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad hoc committee.","volume":"37","author":"Barceloux","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"key":"R13-3-20210126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/15563659709001182","article-title":"Antidotes for methanol and ethylene glycol poisoning.","volume":"35","author":"Jacobsen","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"R14-3-20210126","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0002-9343(79)90738-1","article-title":"Severe methanol poisoning: application of a pharmacokinetic model for ethanol therapy and hemodialysis.","volume":"67","author":"McCoy","year":"1979","journal-title":"Am J Med"},{"key":"R15-3-20210126","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.annemergmed.2008.05.008","article-title":"Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole.","volume":"53","author":"Lepik","year":"2009","journal-title":"Ann Emerg Med"},{"key":"R16-3-20210126","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.emc.2007.02.001","article-title":"Management of beta-adrenergic blocker and calcium channel antagonist toxicity.","volume":"25","author":"Kerns","year":"2007","journal-title":"Emerg Med Clin N Am"},{"key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/01.CCM.0000278916.04569.23","article-title":"Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil.","volume":"35","author":"Levine","year":"2007","journal-title":"Crit Care Med"},{"key":"R18-3-20210126","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/00003246-199507000-00016","article-title":"Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine.","volume":"23","author":"Kline","year":"1995","journal-title":"Crit Care Med"},{"key":"R19-3-20210126","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0024-3205(81)90457-4","article-title":"The actions of insulin on cardiac contractility.","volume":"29","author":"Farah","year":"1981","journal-title":"Life Scu"},{"key":"R20-3-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00139709-200423040-00002","article-title":"The role of insulin and glucose therapy in acute calcium channel antagonist and beta-blocker poisoning.","volume":"23","author":"Megarbane","year":"2004","journal-title":"Toxicol Rev"},{"key":"R21-3-20210126","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1081\/CLT-100102437","article-title":"Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning.","volume":"37","author":"Yuan","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"key":"R22-3-20210126","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM200105313442215","article-title":"Treatment of calcium-channel-blocker intoxication with insulin infusion.","volume":"344","author":"Boyer","year":"2001","journal-title":"N Engl J Med"},{"key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0300-9572(03)00026-1","article-title":"Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review.","volume":"57","author":"Marques","year":"2003","journal-title":"Resuscitation"},{"key":"R24-3-20210126","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-007-0768-y","article-title":"Relative safety of hyperinsulinaemiaeuglycemia therapy in the management of calcium channel blocker overdose: a prospective observational study.","volume":"33","author":"Greene","year":"2007","journal-title":"Intensive Care Med"},{"key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning.","volume":"49","author":"Engebretsen","year":"2011","journal-title":"Clin Toxicol"},{"key":"R27-3-20210126","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.RES.22.6.777","article-title":"Cardiac actions of glucagon.","volume":"22","author":"Lucchesi","year":"1968","journal-title":"Circ Res"},{"key":"R28-3-20210126","doi-asserted-by":"crossref","first-page":"12437","DOI":"10.1074\/jbc.272.19.12437","article-title":"Arachidonic acid drives mini-glucagon action in cardiac cells.","volume":"272","author":"Sauvadet","year":"1997","journal-title":"J Biol Chem"},{"key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM197109302851414","article-title":"The role of glucagon in cardiac therapy.","volume":"285","author":"Parmley","year":"1971","journal-title":"N Engl J Med"},{"key":"R31-3-20210126","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0196-0644(84)80337-6","article-title":"Recognition and management of poisoning with beta-blocking agents.","volume":"13","author":"Weinstein","year":"1984","journal-title":"Ann Emerg Med"},{"key":"R32-3-20210126","first-page":"483","article-title":"Effect of flumazenil on benzodiazepine-induced respiratory depression.","volume":"12","author":"Shalansky","year":"1993","journal-title":"Clin Pharm"},{"key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0196-0644(96)70191-9","article-title":"Emperic use of flumazenil in comatose patients: limited applicability of criteria to define low risk.","volume":"27","author":"Gueye","year":"1996","journal-title":"Ann Emerg Med"},{"key":"R34-3-20210126","first-page":"292","article-title":"Flumazenil and seizures: analysis of 43 cases.","volume":"14","author":"Spivey","year":"1992","journal-title":"Clin Ther"},{"key":"R35-3-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000116684","article-title":"Risks and benefits of therapy with flumazenil (Anexate) in mixed drug intoxications.","volume":"31","author":"Geller","year":"1991","journal-title":"Eur Neurol"},{"key":"R37-3-20210126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00003246-199602000-00004","article-title":"Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients.","volume":"24","author":"Weinbroum","year":"1996","journal-title":"Crit Care Med"},{"key":"R38-3-20210126","first-page":"280","article-title":"Continuous intravenous flumazenil infusion for benzodiazepine poisoning.","volume":"42","author":"Brammer","year":"2000","journal-title":"Vet Hum Toxicol"},{"key":"R39-3-20210126","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1592\/phco.23.14.1513.31941","article-title":"Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.","volume":"23","author":"Maxa","year":"2003","journal-title":"Pharmacotherapy"},{"key":"R40-3-20210126","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1345\/aph.1K244","article-title":"Use of lipid emulsion to reverse local anesthetic-induced toxicity.","volume":"41","author":"Corman","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R41-3-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000542-200607000-00033","article-title":"Successful use of a 20 lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest.","volume":"105","author":"Rosenblatt","year":"2006","journal-title":"Anesthesiology"},{"key":"R42-3-20210126","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/ALN.0b013e31825ad8de","article-title":"Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose.","volume":"117","author":"Weinberg","year":"2012","journal-title":"Anesthesiology"},{"key":"R43-3-20210126","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2044.2006.04740.x","article-title":"Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion.","volume":"61","author":"Litx","year":"2006","journal-title":"Anaesthesia"},{"key":"R44-3-20210126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1865-1380-5-8","article-title":"Case report: successful lipid resuscitation in multidrug overdose with predominant tricyclic antidepressant toxidrome.","volume":"5","author":"Harvey","year":"2012","journal-title":"Int J Emerg Med"},{"key":"R45-3-20210126","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/0003-4819-154-4-201102150-00018","article-title":"Lipid emulsion therapy for verapamil overdose.","volume":"154","author":"Franxman","year":"2011","journal-title":"Ann Intern Med"},{"key":"R46-3-20210126","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1197\/j.aem.2005.08.016","article-title":"Intralipid prolongs survival in a rat model of verapamil toxicity.","volume":"13","author":"Tebbutt","year":"2006","journal-title":"Acad Emerg Med"},{"key":"R47-3-20210126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jemermed.2010.11.055","article-title":"Lipid emulsion as rescue therapy in lamotrigine overdose.","volume":"42","author":"Castanares-Zapatero","year":"2011","journal-title":"J Emerg Med"},{"key":"R48-3-20210126","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.annemergmed.2007.06.004","article-title":"Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine.","volume":"51","author":"Sririanni","year":"2008","journal-title":"Ann Emerg Med"},{"key":"R49-3-20210126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/rapm.2003.50041","article-title":"Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity.","volume":"28","author":"Weinberg","year":"2003","journal-title":"Reg Anesth Pain Med"},{"key":"R50-3-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13181-010-0125-3","article-title":"ACTM position statement: interim guidance for the use of lipid resuscitation therapy.","volume":"7","year":"2011","journal-title":"J Med Toxicol"},{"key":"R51-3-20210126","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2044.2008.05816.x","article-title":"Guidelines and the adoption of lipid rescue therapy for local anesthetic toxicity.","volume":"64","author":"Picard","year":"2009","journal-title":"Anaesthesia"},{"key":"R52-3-20210126","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1197\/j.aem.2006.10.094","article-title":"Hemodynamic effects of intravenous fat emulsion plus standard therapy in a model of severe verapamil toxicity.","volume":"14","author":"Bania","year":"2007","journal-title":"Acad Emerg Med"},{"key":"R53-3-20210126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MEJ.0b013e32834130ab","article-title":"Diltiazem poisoning treated with hyperinsulinemic euglycemia therapy and intravenous lipid emulsion.","volume":"18","author":"Montiel","year":"2011","journal-title":"Eur J Emerg Med"},{"key":"R54-3-20210126","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose.","volume":"367","author":"Boyer","year":"2012","journal-title":"N Engl J Med"},{"key":"R55-3-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jama.1974.03230260019008","article-title":"Hypertensive reaction to naloxone.","volume":"228","author":"Tanaka","year":"1974","journal-title":"JAMA"},{"key":"R56-3-20210126","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000542-197710000-00009","article-title":"Acute pulmonary edema following naloxone reversal of high-dose morphine anesthesia.","volume":"47","author":"Flacke","year":"1977","journal-title":"Anesthesiology"},{"key":"R58-3-20210126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0196-0644(86)80994-5","article-title":"A dosing nomogram for continuous infusion intravenous naloxone.","volume":"15","author":"Goldfrank","year":"1986","journal-title":"Ann Emerg Med"},{"key":"R59-3-20210126","first-page":"1052","article-title":"Acetaminophen intoxication and length of treatment: how long is long enough Pharmacotheapy.","volume":"23","author":"Kociancic","year":"2003","journal-title":""},{"key":"R60-3-20210126","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJM199411103311913","article-title":"Acetaminophen poisoning and liver function.","volume":"331","author":"Smilkstein","year":"1994","journal-title":"N Engl J Med"},{"key":"R62-3-20210126","first-page":"409","article-title":"Oral or intravenous N-acetylcysteine for acetaminophen poisoning Ann Emerg Med.","volume":"45","author":"Prescott","year":"2005","journal-title":""},{"key":"R63-3-20210126","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose.","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N Engl J med"},{"key":"R66-3-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1081\/CLT-100102406","article-title":"Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose.","volume":"37","author":"Wright","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"key":"R67-3-20210126","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccc.2012.07.006","article-title":"A review of acetaminophen poisoning.","volume":"28","author":"Hodgman","year":"2012","journal-title":"Crit Care Clin"},{"key":"R68-3-20210126","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.annemergmed.2007.01.015","article-title":"Patient tailored acetylcysteine administration.","volume":"50","author":"Dart","year":"2007","journal-title":"Ann Emerg Med"},{"key":"R69-3-20210126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2125.2001.01305.x","article-title":"Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning.","volume":"51","author":"Schmidt","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"R70-3-20210126","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/emj.18.4.236","article-title":"Tricyclic antidepressant overdose: a review.","volume":"18","author":"Kerr","year":"2001","journal-title":"Emerg Med J"},{"key":"R71-3-20210126","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0735-6757(93)90163-6","article-title":"Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose.","volume":"11","author":"Hoffman","year":"1993","journal-title":"Am J Emerg Med"},{"key":"R72-3-20210126","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM198508223130804","article-title":"Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants.","volume":"313","author":"Boehnert","year":"1985","journal-title":"N Engl J Med"},{"key":"R73-3-20210126","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-6757(94)90165-1","article-title":"Cyclic antidepressant overdose: a review of current management strategies.","volume":"12","author":"Newton","year":"1994","journal-title":"Am J Emerg Med"},{"key":"R74-3-20210126","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(77)91189-8","article-title":"Sodium bicarbonate and tricyclic antidepressant poisoning.","volume":"1","author":"Brown","year":"1977","journal-title":"Lancet"},{"key":"R75-3-20210126","first-page":"1457","article-title":"Use of sodium bicarbonate to treat tricyclic antidepressant-induced arrhythmias in a patient with alkalosis.","volume":"130","author":"Mollow","year":"1984","journal-title":"Can Med Assoc J"},{"key":"R76-3-20210126","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.emc.2007.02.012","article-title":"Emergency department management of the salicylate-poisoned patient.","volume":"25","author":"OMalley","year":"2007","journal-title":"Emerg Med Clin N Am"},{"key":"R77-3-20210126","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/archinte.1981.00340030096017","article-title":"Acute and chronic effects of aspirin toxicity and their treatment.","volume":"141","author":"Temple","year":"1981","journal-title":"Ann Intern Med"}],"container-title":["Critical Care Nursing Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CNQ.0b013e3182a10cbd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:57:31Z","timestamp":1620950251000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002727-201310000-00003"}},"subtitle":["Management Using Reversal Agents and Antidotes"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cnq.0b013e3182a10cbd","relation":{},"ISSN":["0887-9303"],"issn-type":[{"value":"0887-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}